|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $2,279 and $2,750, respectively | ||||||||||||||||||
| Inventories | ||||||||||||||||||
| Derivative assets | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Other long-term assets | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||
| Short-term debt | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Supply chain finance program | ||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||
| Convertible notes payable - related party, net | ||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Series A Convertible Preferred Shares, $0.01 par value, 24,000 shares authorized, 23,511 shares and 23,511 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively, $11.50 liquidation value | ||||||||||||||||||
| Series A Redeemable Common Equivalent Preferred Shares | ||||||||||||||||||
| Shareholders' Equity (Deficit) | ||||||||||||||||||
| Common stock, $0.01 par value, 300,000 shares authorized, 97,631 shares and 96,866 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||
| Total shareholders' equity (deficit) | ||||||||||||||||||
| Total Liabilities, Convertible Preferred Shares and Shareholders' Equity (Deficit) | ||||||||||||||||||
Loading...